Axa Launches EUR 470.8 Million Buyback to Neutralize Shareplan 2026 Dilution

Axa repurchases up to EUR 470.8M of its own stock for cancellation to offset Shareplan 2026 dilution, as ICC ends its health insurance contract.

Axa has moved to shield shareholders from the dilutive effect of its employee share ownership scheme, striking a deal on Thursday to repurchase up to EUR 470.8 million worth of its own stock for cancellation. The buyback is designed to offset the new shares issued under the group's Shareplan 2026 program, and the purchase price will be determined over a 20-trading-day window that kicked off on Friday. The transactions are scheduled to wrap up no later than October 29.

The repurchase comes against a softer backdrop for the French insurer's equity. The stock closed Thursday at EUR 42.27, down 1.1%, extending its weekly decline to 4.8%. During Friday's session the shares were off a further 1.2% at EUR 42.21, leaving them well below their 52-week high of EUR 45.89.

ICC Contract Ends Amid Sanctions Risk

News from The Hague added to the pressure. The International Criminal Court terminated its health insurance contract with Axa by mutual agreement, effective October 1. According to a Financial Times report, the risk of potential extraterritorial US sanctions lay behind the decision, and Reuters noted that the development weighed on the share price during Thursday's trading.

Axa also continued to reshape its personnel and organizational map. Within its industrial arm AXA XL, Dr. Thomas Götting took over as Chief Client & Distribution Officer for Asia-Pacific and Europe on Thursday. The division additionally established AXA XL E&S, a standalone entity for US specialty insurance business written through wholesale brokers.

"Growing Forward" Targets 100 Million Customers

These moves form part of a broader repositioning. Chief executive Thomas Buberl unveiled the "Growing Forward" roadmap for 2027 to 2029 at Bank of America's 31st Annual Financials CEO Conference, centering on a substantial expansion of the group's global customer base and tangible financial gains from modern information technology. Management is targeting 100 million customers, with artificial intelligence expected to deliver an additional EUR 500 million to EUR 700 million in profit over the life of the program, net of the associated investments. The plan also sets an annual growth target of 7% to 9% for operating earnings per share, with emphasis on organic growth, cost discipline, prevention and a group-wide AI rollout.

The strategy follows earlier operational adjustments, including the creation of AXA XL Excess & Surplus and job cuts at AXA UK.

Analysts Split on Valuation

Sell-side analysts recalibrated their models after the presentation. RBC Capital Markets trimmed its price target to EUR 52 from EUR 54 on September 25 while keeping an "Outperform" rating. Analyst Ben Cohen attributed the revision in part to unchanged payout targets in the multi-year plan and lower buyback expectations, which temper earnings-per-share forecasts. Against that backdrop, the newly launched repurchase primarily serves to protect against dilution rather than to deliver capital returns beyond that purpose.

Not all houses turned more cautious. The DZ Bank upgraded the stock to "Buy" on September 22, and Jefferies reaffirmed its buy recommendation the same day with a price target of EUR 52.50, according to media reports. The bullish stance reflects confidence that the insurer can hit its distribution and technology goals on schedule. For investors, the coming quarters will hinge on how quickly the strategy's first steps translate into measurable operating progress.